A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization ...

The Food and Drug Administration has approved a new drug from Merck designed to protect infants from respiratory syncytial ...

The FDA has approved Enflonsia (clesrovimab-cfor) for the prevention of RSV lower respiratory tract disease in neonates and infants who are born during or entering their first RSV season.

People in Northern Ireland are being reminded that a potentially life-saving vaccination aimed at protecting newborns and ...

Here’s what causes colds to spread so easily, how long they are usually contagious and how they’re most commonly treated.

The OUTPOST study (OUTcomes POST COVID) aims to track 1,500 Australians aged 12 and over who are currently experiencing flu-like symptoms. Participants will be monitored from the onset of their ...

The number of Australians vaccinated against influenza is "worryingly low", health experts say, as new data reveal the winter ...

Scientists and analysts express concern that the newly appointed members—which include known anti-vaxxers—could relitigate ...

After soaring to success in the early days of the COVID-19 pandemic, Moderna (NASDAQ: MRNA) experienced a reversal of fortune ...

Rep Kim Schrier, MD, (D-Wash.), said on X yesterday that some of the newly appointed ACIP replacements are anti-vaccine ...

An Auckland high school closed early today after sickness left it unable to staff all classes, and as a top GP warns that the ...